NCT00086528 2022-05-13Safety and Pharmacokinetics of XL647 Administered Orally to Subjects With Solid TumorsKadmon Corporation, LLCPhase 1 Completed41 enrolled
NCT00336765 2022-05-13Study of XL647 Administered Orally Daily to Patients With Solid TumorsKadmon Corporation, LLCPhase 1 Completed31 enrolled